Use of circulating tumor DNA (ctDNA) to affect the adjuvant or post-adjuvant treatment of patients with stage III and high-risk stage II resected colon cancer: The ERASE-CRC project by GONO. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results